[{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"fa883fb9497018048a05f07ddd4c84a6105cb8e5feada4c64a42b4e7aa09958d","section":"requirements","status":"invalid","value_json":null,"candidate_json":"{\"nodes\":[{\"children\":[\"n1\",\"n2\"],\"condition\":null,\"course\":null,\"evidence\":\"PHM SCI 770or PHARMACY 770 prior to Fall 2026\",\"id\":\"n0\",\"kind\":\"any\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770\",\"id\":\"n1\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHARMACY\"],\"timing\":\"prior\"},\"evidence\":\"PHARMACY 770\",\"id\":\"n2\",\"kind\":\"course\"}],\"notes\":[\"The course PHARMACY 770 is mentioned in requirements_text but is not present in linked_courses. This reference is kept as a verbatim condition leaf. Status is needs_review due to this missing canonical reference.\"],\"root\":\"n0\",\"status\":\"needs_review\"}","error":"Course requirement is absent from the source links","model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"fa883fb9497018048a05f07ddd4c84a6105cb8e5feada4c64a42b4e7aa09958d","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences\"}],\"text\":\"Background in CNS pharmacology, chemical properties of drugs, and molecular signaling, typically from PHMSCI 770 or PHARMACY 770, and enrollment in the MS Pharmaceutical Sciences program.\"}],\"search_phrases\":[\"CNS drug design GABAergic adrenergic\",\"pharmaceutical applications molecular cellular\",\"PHMSCI 771 prerequisites\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\"}],\"text\":\"Written communication skills for integrating chemical, molecular, cellular, and systems information to explain drug discovery and applications.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"}],\"text\":\"PHMSCI 771 applies molecular and anatomical knowledge to understand medical applications of CNS drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"molecular and anatomical factors that influence the actions of central nervous system active drugs\"}],\"text\":\"Molecular and anatomical factors influencing CNS drug actions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\"}],\"text\":\"Medical applications of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drugs\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds\"}],\"text\":\"Integration of chemical, molecular, cellular, and systems information in drug discovery and development\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"fa883fb9497018048a05f07ddd4c84a6105cb8e5feada4c64a42b4e7aa09958d","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"84670ad1c450d07f346a91a1f5d335bfa86a09dcb3db691e1fb0230d54fa7522","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770\",\"id\":\"n0\",\"kind\":\"course\"}],\"notes\":[\"The requirements_text mentions both PHM SCI 770 and PHARMACY 770. PHARMACY 770 is excluded because it is absent from the source links. Only PHM SCI 770 is included as it is present in linked_courses.\"],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"84670ad1c450d07f346a91a1f5d335bfa86a09dcb3db691e1fb0230d54fa7522","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences\"}],\"text\":\"Background in CNS pharmacology, chemical properties of drugs, and molecular signaling, typically from PHMSCI 770 or PHARMACY 770, and enrollment in the MS Pharmaceutical Sciences program.\"}],\"search_phrases\":[\"CNS drug design GABAergic adrenergic\",\"pharmaceutical applications molecular cellular\",\"PHMSCI 771 prerequisites\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\"}],\"text\":\"Written communication skills for integrating chemical, molecular, cellular, and systems information to explain drug discovery and applications.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"}],\"text\":\"PHMSCI 771 applies molecular and anatomical knowledge to understand medical applications of CNS drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"molecular and anatomical factors that influence the actions of central nervous system active drugs\"}],\"text\":\"Molecular and anatomical factors influencing CNS drug actions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\"}],\"text\":\"Medical applications of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drugs\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds\"}],\"text\":\"Integration of chemical, molecular, cellular, and systems information in drug discovery and development\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"84670ad1c450d07f346a91a1f5d335bfa86a09dcb3db691e1fb0230d54fa7522","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-789789da373eecc1ff75f626","output_id":"f436652b64d075d489e6a7496da4168daacbc92684fa75872ed7ccb4f483063e","section":"requirements","status":"needs_review","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770\",\"id\":\"n0\",\"kind\":\"course\"}],\"notes\":[\"The requirements_text mentions both PHM SCI 770 and PHARMACY 770. PHARMACY 770 is excluded because it is absent from the source links. Only PHM SCI 770 is included as it is present in linked_courses.\"],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-789789da373eecc1ff75f626","output_id":"f436652b64d075d489e6a7496da4168daacbc92684fa75872ed7ccb4f483063e","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences\"}],\"text\":\"Background in CNS pharmacology, chemical properties of drugs, and molecular signaling, typically from PHMSCI 770 or PHARMACY 770, and enrollment in the MS Pharmaceutical Sciences program.\"}],\"search_phrases\":[\"CNS drug design GABAergic adrenergic\",\"pharmaceutical applications molecular cellular\",\"PHMSCI 771 prerequisites\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\"}],\"text\":\"Written communication skills for integrating chemical, molecular, cellular, and systems information to explain drug discovery and applications.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"}],\"text\":\"PHMSCI 771 applies molecular and anatomical knowledge to understand medical applications of CNS drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"molecular and anatomical factors that influence the actions of central nervous system active drugs\"}],\"text\":\"Molecular and anatomical factors influencing CNS drug actions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\"}],\"text\":\"Medical applications of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drugs\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds\"}],\"text\":\"Integration of chemical, molecular, cellular, and systems information in drug discovery and development\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-789789da373eecc1ff75f626","output_id":"f436652b64d075d489e6a7496da4168daacbc92684fa75872ed7ccb4f483063e","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"68305504318c3f71a17d6f0976ad41e0302d75166d965834e3ffcd7d019e1e51","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770\",\"id\":\"n0\",\"kind\":\"course\"}],\"notes\":[\"The requirements_text mentions both PHM SCI 770 and PHARMACY 770. PHARMACY 770 is excluded because it is absent from the source links. Only PHM SCI 770 is included as it is present in linked_courses.\"],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"68305504318c3f71a17d6f0976ad41e0302d75166d965834e3ffcd7d019e1e51","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences\"}],\"text\":\"Background in CNS pharmacology, chemical properties of drugs, and molecular signaling, typically from PHMSCI 770 or PHARMACY 770, and enrollment in the MS Pharmaceutical Sciences program.\"}],\"search_phrases\":[\"CNS drug design GABAergic adrenergic\",\"pharmaceutical applications molecular cellular\",\"PHMSCI 771 prerequisites\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\"}],\"text\":\"Written communication skills for integrating chemical, molecular, cellular, and systems information to explain drug discovery and applications.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"}],\"text\":\"PHMSCI 771 applies molecular and anatomical knowledge to understand medical applications of CNS drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"molecular and anatomical factors that influence the actions of central nervous system active drugs\"}],\"text\":\"Molecular and anatomical factors influencing CNS drug actions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\"}],\"text\":\"Medical applications of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drugs\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds\"}],\"text\":\"Integration of chemical, molecular, cellular, and systems information in drug discovery and development\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"68305504318c3f71a17d6f0976ad41e0302d75166d965834e3ffcd7d019e1e51","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"68305504318c3f71a17d6f0976ad41e0302d75166d965834e3ffcd7d019e1e51","section":"student_summary","status":"valid","value_json":"{\"context_hash\":\"1989dc4ceafe82743b0f104299c3f7cb5d1d7060e8a75b7faba96dcc9ebeeef3\",\"course_id\":\"PHMSCI 771\",\"current_instructors\":[],\"difficulty_workload\":[],\"errors\":[],\"historical_context\":[],\"message\":\"No course-specific reviews available\",\"offered\":false,\"profile_hash\":\"5cb4dabf887cdbcd8c00d5a1312e10828b95c63f30bc3ea76aea199565390d02\",\"quick_take\":[],\"student_experience\":[],\"task_hash\":\"74fb0997943e888960bbc9e47db8c4fd12e4292d55c20509d8d89db6a9910f68\",\"teaching_history\":[],\"term_id\":\"1272\",\"term_name\":\"2026 Fall\",\"version\":2}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true}]